Meglumine Production Cost Reports

The report provides a detailed analysis essential for establishing a Meglumine production plant. It encompasses all critical aspects necessary for Meglumine production, including the cost of Meglumine production, Meglumine plant cost, Meglumine production costs, and the overall Meglumine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Meglumine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Meglumine is an organic compound that finds several important applications in the pharmaceutical and medical industries. It is primarily used as a solubilising and stabilising agent in the formulation of various injectable drugs to enhance their solubility and absorption in the body. It finds its major application in the preparation of contrast media for diagnostic imaging, such as X-rays and CT scans, where it helps improve the clarity and quality of internal body images. It is also used as an excipient in the production of certain antibiotics and antiviral medications to enhance absorption and reduce irritation. Additionally, it also finds application in biochemical research and serves as an intermediate in the synthesis of various medicinal compounds and diagnostic agents.

The market for Meglumine is mainly driven by its application as an ingredient in modern drug development and diagnostic products, which significantly boosts its demand in the pharmaceutical industry. Its application as a solubilising and stabilising agent in the production of injectable drugs to improve the bioavailability of active pharmaceutical ingredients largely promotes its demand in the pharmaceutical industry. Its usage in the formulation of contrast media and diagnostic agents further enhances its growing demand in the medical and healthcare sectors.

Its involvement in nutraceutical preparations and biochemical research also contributes to the expansion of its market. Furthermore, factors including the availability of raw materials, cost efficiency, compliance with pharmaceutical regulations, and adherence to quality standards are among the major aspects that largely influence industrial Meglumine procurement. Other factors like supplier reliability, logistics efficiency, technological advancements in drug formulation, and growing demand for diagnostic imaging procedures globally play an essential role in shaping the market trends for Meglumine.

Raw Material for Meglumine Production

According to the Meglumine production plant project report, the major raw materials for Meglumine production include Glucose-Monomethylamine.

Production Process of Meglumine

The extensive Meglumine production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of Meglumine involves the process of condensation of glucose and monomethylamine, followed by catalytic hydrogenation. In this process, anhydrous ethanol and dried glucose are added to a reaction vessel, and dried monomethylamine gas is introduced at about 50 degree Celsius. After one to two hours, the reaction mixture becomes clear, forming a glucose methylamine solution, which is maintained at the same temperature for an additional two hours to complete the condensation. Then, the resulting solution is transferred to an autoclave, where hydrogenation is carried out in the presence of Raney nickel as a catalyst at 2.5 MPa and 80–85 degree Celsius. After cooling and releasing the pressure, the upper layer of the meglumine ethanol solution is separated, cooled, and crystallised. The crude crystals obtained are filtered and further refined to produce pure Meglumine as the final product.

Meglumine is also known as N-methylglucamine. It is an amino sugar alcohol derivative that functions as a solubilising and stabilising agent in pharmaceutical formulations. It appears as a white, crystalline powder that has a slightly sweet taste. The compound is odourless and freely soluble in water and methanol but insoluble in ether and chloroform. The molecular formula of meglumine is C7H17NO5, and its molar mass is 195.21 g/mol. The density of the compound is approximately 1.44 g/cm³. Its melting point is in the range of 128–130 degree Celsius, and it decomposes at higher temperatures. The compound is stable under normal conditions and should be stored in a cool, dry place, protected from moisture. It is generally considered safe but may cause irritation if inhaled or comes into contact with skin or eyes. Standard laboratory precautions are highly recommended while handling it.